Chorionic gonadotropin - Wyeth

Drug Profile

Chorionic gonadotropin - Wyeth

Alternative Names: APL; CG; Choriogonadotrophin; Gonadotrophin chorionic; Gonadotropin chorionic; Human chorionic gonadotrophin; Human chorionic gonadotropin; Pregnancy urine hormone

Latest Information Update: 25 Oct 2000

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Wyeth
  • Developer Nonindustrial source; Wyeth
  • Class Infertility therapies; Peptide hormones; Pituitary gonadotropins; Placental hormones
  • Mechanism of Action Apoptosis stimulants; Ribonuclease stimulants; RNA inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Kaposi's sarcoma

Most Recent Events

  • 15 Mar 2016 Biomarkers information updated
  • 25 Oct 2000 No-Development-Reported for Kaposi's sarcoma in United Kingdom (IM)
  • 25 Oct 2000 No-Development-Reported for Kaposi's sarcoma in USA (Intralesional)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top